Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan

Stage ≤ II Primary urethral carcinoma has favorable survival following definitive treatment, Stage III-IV disease showed poor outcomes, necessitating multimodal perioperative strategies (chemotherapy and/or radiotherapy).

Authors

Institutions

Publication Details

Journal
International Journal of Urology
Published
2026-02-01
DOI
https://doi.org/10.1111/iju.70367
Citations
1
Primary Topic
Urinary and Genital Oncology Studies
Type
article
Field-Weighted Citation Impact
39.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan

H. Enokida, Kohei Kobatake, Taisuke Matsue, Kohei Ogawa et al.
1 citations
International Journal of Urology
Urinary and Genital Oncology Studies
39.15
article

Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan

H. Enokida, Kohei Kobatake, Taisuke Matsue, Kohei Ogawa, Yohei Sekino, TAKUYA TSUJINO, Kei Daizumoto, Yohei Abe, Koji Shiraishi, Rikiya Taoka, Hideo Fukuhara, Shuichi Tatarano, Keiji Inoue, Junya Furukawa, Koichiro Wada, Kiyohide Fujimoto, Minoru Kato, Makito Miyake, Keita Kobayashi, Ryoichi Maenosono
article en
1 citations

Abstract

Stage ≤ II Primary urethral carcinoma has favorable survival following definitive treatment, Stage III-IV disease showed poor outcomes, necessitating multimodal perioperative strategies (chemotherapy and/or radiotherapy).

International Journal of UrologyVol. 33(2)
Kagoshima University (JP), Hiroshima University (JP), Shimane University (JP), Yamaguchi University (JP), Kagawa University (JP), Kochi Medical School Hospital (JP), Osaka Metropolitan University (JP), Nara Medical University (JP), Tokyo Metropolitan University (JP), Osaka University of Pharmaceutical Sciences (JP), Tokushima University (JP)
Good health and well-being
Openalex Percentile: Top 1%
Urinary and Genital Oncology Studies
39.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.